• 儀器無(wú)憂網(wǎng)首頁(yè)
首頁(yè) >  儀器無(wú)憂網(wǎng)品牌優(yōu)搜庫(kù) >  P > PBI

美國(guó) . Pressure BioSciences

logo

PBI

Pressure BioSciences

美PBI  Pressure BioSciences, Inc.  www.pressurebiosciences.com
Pressure BioSciences, Inc. (PBI)美國(guó)高壓生物科學(xué)公司(NASDAQ:PBIO),是世界上最專業(yè)的高壓樣品處理系統(tǒng)研發(fā)和生產(chǎn)廠商。該公司的總部在波士頓,其核心技術(shù)人員為麻省理工學(xué)院,哈佛大學(xué),和耶魯大學(xué)工作過(guò)的博士們。其研制生產(chǎn)的壓力循環(huán)樣品處理系統(tǒng)PCT SPS),為生物樣品前處理提供了前所未有的革命性技術(shù)。

PCT高壓循環(huán)技術(shù)Pressure Cycling Technology 是一項(xiàng)全新、高效的生物樣品制備專利。它利用多次的常壓和超高(液)壓(35,000 PSI或更高)之間壓力快速循環(huán),實(shí)現(xiàn)生物分子精準(zhǔn)提取??梢詮氐赘淖冞^(guò)去、現(xiàn)在和未來(lái)生物領(lǐng)域的各種麻煩的樣品前處理,徹底改變傳統(tǒng)的思路。廣泛的應(yīng)用于法醫(yī)鑒定樣品處理,基因組學(xué)和蛋白質(zhì)組學(xué)研究樣品處理,藥物研發(fā),環(huán)境科學(xué)等。

We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.
Our pressure cycling technology uses internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures to rapidly and repeatedly control the interactions of bio-molecules. Our instrument, the Barocycler®, and our internally developed consumables product line, which includes PULSE (Pressure Used to Lyse Samples for Extraction) Tubes as well as the ProteoSolveLRS™ kit for the detergent-free extraction of proteins from lipid-rich samples, together make up the PCT Sample Preparation System ("PCT SPS").
Our pressure cycling technology employs a unique approach that we believe has the potential for broad applications in a number of established and emerging life sciences areas, including;
Sample preparation for genomic, proteomic, and small molecule studies;
Pathogen inactivation;
Protein purification;
Control of chemical (enzymatic) reactions; and
Immunodiagnostics

Since we began operations as Pressure BioSciences in February 2005, we have focused substantially all of our research and development and commercialization efforts on sample preparation for genomic, proteomic, and small molecule studies.
Our business strategy is to commercialize pressure cycling technology in the area of sample preparation for genomic, proteomic, and small molecule studies ("sample preparation"). We also plan to pursue the further development and commercialization of PCT in other life sciences applications, which could include working with various strategic partners that have greater scientific, and regulatory, expertise in the respective applications than we do.